Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Ness County Hospital Implements Prognosis HIS EHR in Just Four Months

June 27, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

HOUSTON, June 27, 2011 /- Ness County Hospital recently began using the ChartAccess® Comprehensive EHR, just four months after the critical access hospital selected the Prognosis Health Information Systems solution. "The Ness go-live raises the bar by setting a new standard for EHR...

InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation

June 27, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

TEL-AVIV, Israel, June 27, 2011 /- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced it has signed a distribution agreement with IMPLANTA, a well-established Moscow-based supplier to medical...

Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index

June 27, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., June 27, 2011 /- Pacira Pharmaceuticals, Inc ., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that it has been included in the Russell 3000® Index following Russell Investments' reconstitution of its comprehensive set of U.S. and...

Advertisement

Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA

June 27, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., June 27, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ) and Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Columbia's New Drug Application (NDA) for PROCHIEVE...

Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders

June 27, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

SEATTLE, June 27, 2011 /- Omeros Corporation (NASDAQ: OMER ) today reported that it has identified compounds that interact with orphan G protein-coupled receptors (GPCRs) P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated with acute lymphoblastic leukemia (ALL), an aggressive cancer...

Cellular Dynamics International Unlocks the Potential of Banked Blood Samples

June 27, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 27, 2011 /- Cellular Dynamics International (CDI) today announced the online publication of an article in the journal Blood demonstrating for the first time a methodology for researchers to access the biology stored in repositories of banked blood samples through the...

Dehaier Strengthens Intellectual Property Portfolio

June 27, 2011 3:31 am | by Bio-Medicine.Org | News | Comments

BEIJING, June 27, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it was...

MCRA Launches Compliance and Business Ethics Hotline

June 27, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 27, 2011 /- Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA), an independent medical technology consulting firm focusing on regulatory, clinical, intellectual property, quality assurance, healthcare compliance and reimbursement strategy execution, is pleased to...

Advertisement

ASP Launches GLOSAIRâ„¢ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities

June 27, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., June 27, 2011 /- Advanced Sterilization Products (ASP) announced today the launch of an innovative infection prevention technology – GLOSAIR™ Healthcare Environmental Decontamination – that provides effective, safe(1) and thorough disinfection of hospital...

Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes

June 27, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

THE WOODLANDS, Texas, June 27, 2011 /- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that the company presented clinical data from a mechanistic study of LX4211 , a dual...

Biopsy Screen Can Save a Spleen

June 27, 2011 2:33 am | by Diagnostic Imaging | News | Comments

Image-guided percutaneous biopsy is a viable substitute for splenectomy while causing fewer complications for patients, a new study published in the journal Radiology has found.

Consistent Policies Help Radiology Practices

June 27, 2011 2:33 am | by Diagnostic Imaging | News | Comments

Lack of uniformity negatively impacts the quality of your care most importantly. It will cost patients time, and cost the practice time, possibly you personally. It also makes the practice appear haphazard and un-professional.

Reportlinker Adds Key Companies: HIV - Companies Co-Operate and Co-Formulate to Stay Competitive in a Tight HIV Market

June 27, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 27, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Key Companies: HIV - Companies co-operate and co-formulate to stay competitive in a tight HIV market...

Advertisement

Reportlinker Adds Product Profiles: Depression - Next generation Vies for Second-Line Patients

June 27, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 27, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Product Profiles: Depression - Next generation vies for second-line patients...

Reportlinker Adds India Biopharmaceuticals Market

June 27, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 27, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: India Biopharmaceuticals market...

Reportlinker Adds Product Profiles: Multiple Sclerosis - Gilenya Raises Bar for New Market Entrants

June 27, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 27, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Product Profiles: Multiple Sclerosis - Gilenya raises bar for new market entrants...

Lantus®/Apidra® SoloSTAR® Help to Improve Patient Satisfaction

June 26, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

PARIS, June 27, 2011 /-   Sanofi (EURONEXT: SAN and NYSE: SNY ) announced today, at the 71 st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus ® and/or Apidra ® with the...

ERA-EDTA Congress 2011: Late Breaking Clinical Trials II

June 25, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

PRAGUE, June 25, 2011 /-   The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatinleads to a significant reduction in major atherosclerotic events among CKD-patients. Whether it also has a favourable effect on renal disease progression was another of the...

MHT's Emerging Technology Forum looks at Superhero tech

June 24, 2011 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

From tabletop collaboration tools to brain control of remote devices and a powerful exoskeleton, innovators provided a glimpse into the future today during Mass High Tech's Emerging Technology Forum at Microsoft's NERD Center in Cambridge.

Daniels Jumps to No. 2 in Medical Waste Disposal Industry

June 24, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

BRONX, N.Y., June 24, 2011 /- Daniels Sharpsmart Inc., the world's largest provider of reusable systems for sharps disposal, has acquired the Bronx medical waste facility from Stericycle making Daniels the second largest medical waste disposal company in North America. (Photo:...

Have Body Check Anytime & Anywhere With Portable Products

June 24, 2011 10:33 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 24, 2011 /PRNewswire-Asia/ -- High efficiency is the key to both people and products winning in serious competition, and how to save time is the key to high efficiency. The new arrival of medical product sets offered by Shenzhen Wuzhou Changlian Trading Co., a...

Erythropoiesis-Stimulating Agents (ESAs) In Chronic Kidney Disease: Drug Safety Communication - Modified Dosing Recommendations

June 24, 2011 8:31 am | by U.S. Food & Drug Administration | News | Comments

Increased risks of cardiovascular events using ESAs in this patient population.

Stanmore Receives US FDA Approval for its JTS Non-invasive Extendible Implant

June 24, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

LONDON, June 24, 2011 /-   Stanmore Implants ("Stanmore"), specialists in the design and manufacture of patient specific implants for complex orthopaedic reconstructions, announces that it has received US FDA 510k approval for its Juvenile Tumour System ("JTS") non-invasive...

MDCT Highly Accurate in Spotting Acute Appendecitis

June 24, 2011 7:32 am | by Diagnostic Imaging | News | Comments

The dramatic increases in the use of Multidetector CT scanners (MDCT) prior to surgery in cases of acute appendicitis appear justified by their diagnostic abilities, a new study suggests.

Surviving in a Tough Market

June 24, 2011 7:32 am | by Diagnostic Imaging | News | Comments

Advice from Andy Savo on negotiating the new marketplace

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading